A phase II study (PX-171-003-A1) of single-agent carfilzomib in patients with advanced relapsed and refractory multiple myeloma (RRMM)D. S. Siegel,T. Martin,M. Wang,R. Vij,A. J. Jakubowiak,S. Lonial,S. Trudel,V. Kukreti,N. Bahlis,M. Alsina,A. Chanan-Khan,F. Buadi, F. J. Reu,G. Somlo,J. Zonder,K. Song,A. K. Stewart,E. Stadtmauer,L. Kunkel,S. Sandra Wear,A. Wong,R. Z. Orlowski,S. JagannathBRITISH JOURNAL OF HAEMATOLOGY（2013）引用 0|浏览20暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
